Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-24 @ 9:11 PM
NCT ID:
NCT02591004
Eligibility Criteria:
* Inclusion Criteria:
* in imminent preterm labour ( , \>4cm dilated, cervical effacement \> 60%).
* \< 32 weeks gestational age.
* Exclusion Criteria:
* patients will be excluded from the study if the gestational age was \> 32 weeks
* intrauterine fetal death
* multiple gestation
* fetal malformations where only palliative care is needed
* placental abruption
* Chorioamnionitis
* pre-ecplamsia, or diabetes
* suspected fetal compromise diagnosed by ultrasound or CTG requiring delivery, -any indication for caesarean section
* fetal growth restriction
* Also any contraindication to the use of Nifedipine e.g maternal cardiac disease, allergy to Nifedipine, hypotension, or hepatic dysfunction
* Contraindications To MgSo4 use as Myasthenia Gravis, progressive muscle weakness ,allergy to MgSo4, severe renal impairment \& heart block.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
35 Years
Study:
NCT02591004
Study Brief:
Protocol Section:
NCT02591004